Given its significance in the process of tumor progression, Linc00426 may act as a promising predictive biomarker for LUAD, and proper regulation of the Linc00426-miR-455-5p-UBE2V1 axis may be a novel synergistic strategy for inhibiting the process of tumor progression. This evidence concerns the gene UBE2V1 and neoplasm.